School burnout among students with and without disabilities before, during, and after the COVID-19 pandemic
Marja Eliisa Holm,
No information about this author
Päivi Sainio,
No information about this author
Sinna Maija Henriikka Lehtola
No information about this author
et al.
Disability and health journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101841 - 101841
Published: April 1, 2025
Language: Английский
Immigrant Origin and Disability Increase Risk for Anxiety Among Youth During COVID-19: The Role of Unmet Needs for Support in Distance Learning and Family Conflicts
Journal of Adolescent Health,
Journal Year:
2024,
Volume and Issue:
74(5), P. 916 - 924
Published: Feb. 5, 2024
PurposeShifting
to
distance
learning
due
COVID-19
may
decrease
teacher
support
and
increase
family
conflicts,
potentially
increasing
anxiety.
Nevertheless,
there
is
scarce
information
on
this
topic
among
disability
and/or
immigrant-origin
groups.
Thus,
we
investigated
whether
these
minority
groups
reported
more
anxiety
than
the
reference
group—Finnish-origin
youth
without
disabilities—and
unmet
needs
for
in
conflicts
mediated
differences
during
pandemic.
Differences
mediators
were
also
investigated.MethodsPopulation-based
data
of
165,033
aged
12
29
from
cross-sectional
Finnish
School
Health
Promotion
study
obtained
2021
using
total
population
sampling.
Logistic
regressions
with
Stata
used
investigate
between
target
(youth
disabilities,
immigrant
backgrounds,
or
both
characteristics)
The
Karlson–Holm–Breen
method
was
test
mediation.ResultsThe
disabilities
(odds
ratio
[OR]
=
4.14
[95%
confidence
interval
(CI):
4.02–4.27]),
backgrounds
(OR
1.15
CI:
1.06–1.25]),
characteristics
5.03
4.59–5.52])
often
group.
difference
significant.
Immigrant-origin
most
vulnerable
prone
needs.
Unmet
accounted
28%
association
anxiety,
whereas
mediating
percentage
smaller
(13%)
Finnish-origin
(11%).DiscussionImmigrant-origin
need
targeted
prevent
Alleviating
crises
could
help
Support
should
be
provided
regardless
their
backgrounds.
Language: Английский
Adolescent depression treatment pathways in Primary Care – protocol for a longitudinal Cohort Study Describing Naturalistic Flow of Treatment and Evaluating Effectiveness and Cost- effectiveness of Interpersonal Counseling Compared to Treatment as Usual
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 23, 2024
Abstract
Background:Implementation
of
evidence-based
interventions
is
one
the
proposed
responses
to
increased
demand
for
treatment
adolescent
depression.
While
efficacy
interpersonal
psychotherapy
treat
depression
adolescents
(IPT-A)
well
established,
effectiveness
and
cost-effectiveness
shorter
counseling
(IPC-A)
remains
open.
Objective:
We
present
a
protocol
prospective
evaluation
naturalistic
flow
with
sustained
depression,
IPC-A,
as
compared
usual
or
no
Methods:
will
collect
cohort
grade
7
9
(13–16-year-olds)
in
selected
Finnish
schools
using
convenience
sampling
(n=9000).
We
compare
three
groups
defined
at
6
months
(targeting
n=100;
(TAU),
n=200;
treatment,
n=100).
The
primary
outcome
measure
will
be
proportion
who
received
specialized
psychiatric
services
by
2
years
after
baseline.
Secondary
measures
include
longitudinal
changes
PHQ-9-A
scores
12
months,
positive
mental
health,
social
inclusion,
quality
life.
Cost-effectiveness
evaluated
survey
data
an
economic
evaluation
register
information
on
service
use
before
up
10
A
universal
all
adolescents,
independent
mood,
provide
description
a)
sustained
depression
over
follow-up
period
(Patient
Health
Questionnaire
items,
version,
≥
two
measurements
months),
b)
self-reported
need
motivation
support,
c)
therapeutic
intervention,
d)
benefits
harms
treatment.
describe
treatment
received
predictors
based
reports
from
caretakers,
therapists,
electronic
patient
records.
Impact
training
IPC-A
competence
access
evaluated.
Conclusions:
The
study
will
describe
for,
pathways
to,
content
health
depressed
adolescents.
The
results
can
improve
detection
equal
care,
inform
decision
-makers
about
best
practices
prevention,
including
utility
implementation
IPC-A.
Trial
registration:
ClinicalTrials.com
NCT06390462
registered
2024-03-19
Language: Английский